CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS
The analysis of the changes of the content of the angiogenic factor VEGFR-2 in the cytosol of the tumor and blood sera of the 30 breast can- cer patients determined by immunoenzyme method during neoadjuvant therapy is given. Likewise the correlation of this index with the main clinicomorphological c...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-09-01
|
Series: | Опухоли женской репродуктивной системы |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/334 |